Japan Tobacco 2025 H1 Financial Report: Net Profit Up 5% YoY to $2.1 Billion, Heated Tobacco Shipments Rise Nearly 30%

Aug.01.2025
Japan Tobacco 2025 H1 Financial Report: Net Profit Up 5% YoY to $2.1 Billion, Heated Tobacco Shipments Rise Nearly 30%
Japan Tobacco's (JT) 2025 H1 financial report shows year-over-year growth in key metrics, driven by pricing strategy, international business integration, and heated tobacco (HTS) expansion. Net revenue reached approximately $11.5 billion, up 10.5% YoY, while net profit rose 4.8% to about $2.1 billion. HTS shipments hit 5 billion units, a 29.5% YoY increase. The newly launched Ploom AURA reached a 13.6% market share in Japan in Q2.

Key Points:

 

Core business data

 

·Second quarter: Net revenue of 907.6 billion yen (approximately $6 billion ), up 9.4% year-on-year; net profit of 162.4 billion yen (approximately $1.1 billion), up 9.8% year-on-year; adjusted operating profit of 273.3 billion yen (approximately $1.8 billion), up a significant 20.7% year-on-year. 

 

·First half of the year: Net revenue of 1.73 trillion yen (approximately $11.5 billion), up 10.5% year-on-year; adjusted operating profit of 539.9 billion yen (approximately $3.6 billion), up 19.2% year-on-year. 

 

New Tobacco Product (HTS)

 

·In the first half of the year, shipments reached 5 billion units, a significant increase of 29.5% year-on-year. 

 

·In the Japanese market, the new device PloomAURA has tripled its sales in the three weeks since its launch, helping JT's share in the Japanese HTS market rise to 13.6% in the second quarter. 

 

International Business Performance

 

·In the EMA region (including the Americas), tobacco revenue increased by 27.9% year-on-year, with adjusted operating profit surging by 49.8%, mainly driven by the acquisition and integration of the Vector Group in the United States. 

 

·In Western Europe, sales volume decreased by 5.8%, but revenue increased by 3.5% due to pricing strategies, leading to an 8.5% increase in operating profit. 

 

·In Asia (excluding Japan), both revenue and operating profit saw steady growth, increasing by 4.6% and 4.2% respectively. 

 

Outlook for the Full Year and Shareholder Returns

 

·The full-year adjusted operating profit growth forecast has been raised to 14.6% at constant exchange rates; 

 

·Annual earnings per share has been increased from 194 Japanese yen to 208 Japanese yen (approximately $1.4), with a mid-term dividend of 104 Japanese yen (approximately $0.7).

 


[2Firsts News Flash] According to a report on the official website of Japan Tobacco on July 31, Japan Tobacco (JT) has released its financial report for the second quarter and first half of 2025. The report shows that due to strong price strategies in the tobacco business, significant acquisition and integration effects in the United States, and continuous growth of HNB products (HTS), JT has significantly raised its full-year performance guidance for 2025 and announced an increase in annual dividends.

 

 

Core Financial Performance

 

In the second quarter (April-June), growth momentum remained robust, with all key financial indicators showing steady growth.

 

·Net income: 907.6 billion yen (approximately $6 billion), an increase of 9.4% year-on-year. 

 

·Net profit: 162.4 billion yen (approximately $1.1 billion), an increase of 9.8% year-on-year. 

 

·Adjusted operating profit: 273.3 billion yen (approximately $1.8 billion), an increase of 20.7% year-on-year. 

 

 

Cumulative Performance for the First Half of the Year (January to June)

 

·Net income: The cumulative net income for the first half of the year was 1.73 trillion Japanese yen (approximately $11.5 billion), an increase of 10.5% year-on-year.

 

·Net profit: In the first half of the year, it accumulated to 319.9 billion yen (approximately $2.1 billion), an increase of 4.8% compared to the same period last year.

 

·Adjusted operating profit: The accumulated profit for the first half of the year was 539.9 billion yen (approximately $3.6 billion), a 19.2% year-on-year increase.

 

 

Performance of Business Segments (First Half of 2025)

 

Traditional tobacco

 

·Financial performance: Tobacco product revenue was 1.55 trillion yen (approximately $10.3 billion), a year-on-year increase of 11.5%. Adjusted operating profit was 556.1 billion yen (approximately $3.7 billion), a year-on-year increase of 17.8%.

 

·Sales Performance: The total shipment volume was 283.3 billion units, a year-on-year increase of 0.7%, with traditional cigarette sales remaining stable.

 

Highlights of the new Reduced-Risk Products (RRP) business

 

·HTS shows significant growth: HNB product shipments reached 5 billion units in the first half of the year, a substantial increase of 29.5% compared to the same period last year, making it the top priority investment target for the company.

 

·PloomAURA: In May, the new device PloomAURA was launched in Japan and initial sales far exceeded expectations. In the first three weeks after its release, the total sales of devices were approximately three times higher than the previous model. This successful launch helped PloomAURA to capture a market share of 13.6% in the Japanese HTS category in the second quarter.

 

International Business Performance (First Half of 2025)

 

The international business of Japan Tobacco Inc. has shown varying performances in different regions, with the mergers and acquisitions effects being particularly prominent in the Americas.

 

·The EMA (Europe, Middle East, Africa, and Americas) region showed the strongest growth. At constant exchange rates, revenue from tobacco products increased significantly by 27.9%, while adjusted operating profit soared by 49.8%. This was mainly due to the integration effects of the acquisition of Vector Group Ltd. (VGR) in the United States.

 

·Western Europe: Exhibiting the characteristics of "quantity decline, price increase." Despite a 5.8% decrease in total sales volume, under successful pricing strategies, revenue grew by 3.5% at a constant exchange rate, and adjusted operating profits increased by 8.5%.

 

·Asia region (excluding Japan market): Stable performance. With constant exchange rates, tobacco product revenue increased by 4.6%, while adjusted operating profit increased by 4.2%.

 

Future Prospects and Shareholder Returns

 

Based on its strong performance in the first half of the year, JT has significantly raised its full-year earnings outlook and increased its shareholder return plan.

 

·Revised Full-Year Guidance: The company has revised its full-year forecast for adjusted operating profit growth (at constant exchange rates) to 14.6%.

 

·Increase shareholder returns: The company has raised its annual per share dividend expectation from the previous 194 yen to 208 yen (approximately $1.4), with a mid-term dividend of 104 yen (approximately $0.7).

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

IQOS Japan launches three ILUMA i custom bundle sets with leather wrap and premium ring accessories, on sale from Jan 29
IQOS Japan launches three ILUMA i custom bundle sets with leather wrap and premium ring accessories, on sale from Jan 29
According to IQOS Japan’s official website, the company has introduced three custom bundle sets for its IQOS ILUMA i lineup, combining devices with accessories as bundled offerings, and began rolling them out across multiple sales channels from Jan. 29.
Jan.29 by 2FIRSTS.ai
EVO NXT 2026 Offers Unique Insights Into A Dynamic Industry
EVO NXT 2026 Offers Unique Insights Into A Dynamic Industry
Feb.09
2Firsts Interview with Glas |Why a California ENDS Company Believes Its Age-gated Flavored Vape Could Be Next in Line for FDA Authorization
2Firsts Interview with Glas |Why a California ENDS Company Believes Its Age-gated Flavored Vape Could Be Next in Line for FDA Authorization
As the FDA advances efforts to streamline its PMTA review process, including support for small businesses, expectations are rising that additional product authorizations may follow. Age-verification technology is emerging as a key consideration in future approvals.In this interview, California-based Glas discusses its G2 platform, integrating smartphone-based identity verification, proximity controls and anti-counterfeit systems, and outlines its positioning under the FDA’s PMTA framework.
Mar.02
Shanghai releases 2025 smoke-free white paper: smoking incidence at designated smoke-free venues falls to 12.6%
Shanghai releases 2025 smoke-free white paper: smoking incidence at designated smoke-free venues falls to 12.6%
Shanghai released its 2025 White Paper on Smoking Control in Public Places at a city tobacco control meeting on March 5. The paper reports a 12.6% smoking incidence in legally designated smoke-free venues, down 0.4 percentage points from 2024, and says 98.2% of residents support a full indoor smoking ban.
Mar.05
Fiscal benefit, not health, strongest indicator for vape bans – Contributed by Samrat Chowdhery
Fiscal benefit, not health, strongest indicator for vape bans – Contributed by Samrat Chowdhery
Data shows 75% of nations with state stakes in tobacco trade ban modern substitutes compared to 10% in the free-market group. What is driving these divergent regulations?
Feb.04
FDA schedules online roundtable to gather small manufacturers’ input on ENDS PMTA requirements
FDA schedules online roundtable to gather small manufacturers’ input on ENDS PMTA requirements
FDA announced it will convene a Feb. 10, 2026 roundtable with small tobacco product manufacturers to gather feedback on PMTA submissions for ENDS products. The discussion will be viewable online, and a public docket is open for comments through March 12, 2026.
Feb.10 by 2FIRSTS.ai